Mode
Text Size
Log in / Sign up
N/A N=23 Randomized Prevention

Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Milk

Prediabetes

Enrolled (actual)
23
Serious AEs
0.0%
Results posted
May 2019
Primary outcome: Primary: Vascular Endothelial Function — -307; -34.8; -36.8; -110 %*min

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Glucose (Other); Glucose with Non-fat Milk (Other); Glucose with Whey Protein Isolate (Other); Glucose with Sodium Caseinate (Other)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Ohio State University
Primary completion
Jul 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Vascular Endothelial Function
-307; -34.8; -36.8; -110
SECONDARY
Nitrite/Nitrate (NOx)
-1363; 347; -21; -57.2
SECONDARY
Plasma Glucose
5828; 4032; 3340; 3640
SECONDARY
Malondialdehyde (MDA)
66.5; 43.2; 46.4; 45.1
SECONDARY
Arginine (ARG)
-3922; -1235; 195; -189
SECONDARY
Asymmetric Dimethylarginine/Arginine (ADMA/ARG)
275; 55; 47; 25
SECONDARY
Symmetric Dimethylarginine/Arginine (SDMA/ARG)
175; 31; 4; -17
SECONDARY
Tetrahydrobiopterin/Dihydrobiopterin (BH4/BH2)
-47; 78; 171; 131
SECONDARY
Insulin
8179.7; 8196.1; 8654.6; 8656.9
SECONDARY
Cholecystokinin (CCK)
89.67; 422.87; 352.5; 519.94
SECONDARY
8-isoprostaglandin-F2a
2162.2; -824.14; -18.75; 229.14
SECONDARY
8-isoprostaglandin-F2a/Arachidonic Acid
10129; -1655.2; 2422.3; 3907.6
SECONDARY
Arachidonic Acid
-2570; -1358.4; -2762.6; -2752.0

Summary

Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whether these effects occur directly or indirectly by displacing foods in the diet that might increase CVD risk is unclear. The health benefits of dairy on heart health are at least partly attributed to its ability to limit PPH and resulting PPH-mediated responses leading to vascular dysfunction. This provides rationale to further investigate dairy as a dietary strategy to reduce PPH and risk for CVD. The objective of this study is to define the extent to which dairy milk, and its whey and casein protein fractions, protect against postprandial vascular dysfunction by reducing oxidative stress responses that limit nitric oxide bioavailability to the vascular endothelium in adults with prediabetes.

Eligibility Criteria

Inclusion Criteria

  • hemoglobin A1c 5.7-6.4%
  • non-dietary supplement user
  • no medications affecting vasodilation, inflammation, or energy metabolism
  • no CVD
  • nonsmokers
  • individuals having blood pressure 3 drinks/day or >10 drinks/week
  • ≥7 hours/week of aerobic activity
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02482675). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search